What medical treatments are available for my hirsutism?

• Introduction
• Abortion
• Amenorrhoea
• Birth Control
• Bladder Symptoms
• Cancer in Women
• Childbirth
• Children and Teenagers
• Diet / Weight Loss
• Dysmenorrhoea
• Endometriosis
• Fibroids
• HRT
• Hirsutism
• Definition
• Hair Development
• Prevalence
• Assessment and Monitoring
• Androgen Excess Effects
• Androgen Sources
• Diagnosis
• Treatments - Cosmetic
• Dieting Benefits
• Medical Treatments
• The Pill
• Yasmin
• Cyproterone Acetate
• Dianette
• Vaniqa
• Surgical Treatments
• Virilism
• Support Groups
• Hysterectomy
• Infections
• Infertility
• Medication Drugs
• Menopause
• Menorrhagia
• Miscarriage
• Painful Sex
• Pap Smear Test
• PCOS
• Pelvic Pain
• PMS
• Postpartum
• Pregnancy
• Self Esteem
• Sexual Problems
• Vaginal Discharge
• Vaginal Prolapse
• Vulval Symptoms

Underperforming Website?

Visit

Authors:

Dahlgren E. Landin K. Krotkiewski M. Holm G. Janson PO.

Institution

E. Dahlgren, Department Obstetrics and Gynecology, Sahlgrenska University Hospital, Goteborg University, S-41345 Goteborg; Sweden.

Title:

Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. (1998) 08-13-2690

Source:

Human Reproduction. Vol 13(10) (pp706-2711), 1998.

Abstract:

Thirty-two women with polycystic ovary syndrome (PCOS) were allocated to two antiandrogen treatment regimens; 28 women completed the trial. Twenty women were treated with ethinyloestradiol and cyproterone acetate (EO-CA) cyclically for 6 months and eight women were treated with the gonadotrophin releasing hormone (GnRH) analogue, goserelin for 6 months. Effects on hirsutism, insulin sensitivity (estimated by glucose clamp technique), blood lipids and hormones were measured. Women treated with EO-CA showed a reduction in hirsutism (P<0.05), and decreased serum androgen concentrations (P<0.001) as well as reduced insulin sensitivity (P<0.05). In women treated with goserelin, serum androgen concentrations also decreased (P<0.001), but there was no significant reduction of hirsutism. This group, however, showed an improved insulin sensitivity (P<0.05) despite an unchanged body mass index. Bone mineral density was unaltered in both treatment groups. The reduction in androgen concentrations caused by EO-CA was not paralleled by increased insulin sensitivity, most probably due to the effect of ethinyloestradiol per se. In contrast, the reduction in androgen concentrations by goserelin was accompanied by an improved insulin sensitivity.

See Also:

Hirsutism

Alopecia

Thank you for choosing to visit us.

This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT.

I do hope that you find the answers to your women's health questions in the patient information and medical advice provided.